Barry Kusnick
Interventional Cardiology · Daytona Beach, FLNPI 1194788117
Payments from drug & device makers
Across 94 payments — averaging $29.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$506
- E.r. Squibb & Sons, L.L.C.$332
- Abiomed$327
- Abbott$310
- Pfizer$233
- Philips North America LLC$167
- plus $923 from 20 others
What the payments were for
- Food & beverage$2,797100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $506 |
| E.r. Squibb & Sons, L.L.C. | 18 | $332 |
| Abiomed | 8 | $327 |
| Abbott | 5 | $310 |
| Pfizer | 9 | $233 |
| Philips North America LLC | 4 | $167 |
| Kestra Medical Technology Services, Inc. | 1 | $124 |
| Cook Medical LLC | 1 | $109 |
| Boston Scientific | 2 | $108 |
| Novartis | 3 | $102 |
| Innovation Technologies Inc | 1 | $92 |
| Biosense Webster, Inc. | 1 | $82 |
| Johnson & Johnson | 3 | $53 |
| Amarin Pharma, Inc. | 2 | $39 |
| Merck | 3 | $37 |
| Novo Nordisk | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Cvrx, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $14 |
| Amgen | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $13 |
| Terumo Medical Corporation | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,797 in reported general payments places this provider in the 20th percentile of 623 interventional cardiology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 391 | $604,303 |
| XareltoRivaroxaban | 102 | $144,540 |
| EntrestoSacubitril/Valsartan | 70 | $88,508 |
| Repatha SureclickEvolocumab | 21 | $21,050 |
| Verapamil Er PmVerapamil Hcl | 33 | $14,093 |
| Repatha SyringeEvolocumab | 19 | $12,552 |
| Metoprolol Succinate | 525 | $5,392 |
| Valsartan | 126 | $2,635 |
| Midodrine Hcl | 29 | $2,248 |
| Ezetimibe | 182 | $1,949 |
| Testosterone Cypionate | 30 | $1,834 |
| Bumetanide | 44 | $1,726 |
| Digoxin | 110 | $1,672 |
| ClopidogrelClopidogrel Bisulfate | 131 | $1,219 |
| Atorvastatin Calcium | 149 | $1,180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $233 | $604,303391 claims |
| Johnson & JohnsonXarelto | $53 | $144,540102 claims |
| NovartisEntresto | $102 | $88,50870 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Daytona Beach
- Vance WilsonDaytona Beach$746K
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
- Arthur LeeGainesville$2M
- Ruby SatpathyJacksonville$1.8M
- Santhosh MathewsBradenton$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.